Catheter Precision (VTAK) Restructuring Costs (2022)
Catheter Precision's (VTAK) quarterly Restructuring Costs came in at $103000.0 in Q4 2022, down 88.56% quarter-over-quarter from $900000.0 in Q3 2022.
Powered by 
Analysis
Catheter Precision (VTAK) Restructuring Costs (2022) Analysis & Trends
Catheter Precision (VTAK) has reported Restructuring Costs for 1 consecutive years, with $103000.0 the latest figure, recorded in Q4 2022.
- On a quarterly basis, Restructuring Costs changed N/A year-over-year to $103000.0 in Q4 2022; TTM through Dec 2023 was $103000.0, a N/A change from a year earlier, with the FY2022 full-year figure at $4.2 million, changed N/A from the prior year.
- Restructuring Costs was $103000.0 for Q4 2022 at Catheter Precision, down from $900000.0 in the prior quarter.
- Over five years, Restructuring Costs peaked at $3.5 million in Q2 2022 and troughed at $103000.0 in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Catheter Precision | 480,427.59 | -1.36 Mn | 98,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 103,000.00 |
| Sep 30, 2022 | 900,000.00 |
| Jun 30, 2022 | 3.53 Mn |